Immunocompromised individuals face ongoing COVID-19 risks despite vaccination, highlighting the need for tailored public health strategies and innovative therapies.
Chandler H. Park, MD, MS, FACP
Advertisement
Articles by Chandler H. Park, MD, MS, FACP
Explore the latest advancements in sarcoma immunotherapy, focusing on tumor microenvironment modulation and innovative treatment strategies for improved patient outcomes.
Advertisement
Latest Updated Articles
Safeguarding Vulnerability: COVID-19’s Impact on Immunocompromised Patients With CancerPublished: August 15th 2025 | Updated:
Immune Modulation in Sarcoma: Targeting the Tumor MicroenvironmentPublished: July 28th 2025 | Updated:
Advertisement
Advertisement
Trending on CancerNetwork
1
What Were the Key Presentations at ESMO 2025? Oncology Experts Discuss
2
Porustobart/Tislelizumab Elicits Responses in MSS Metastatic Colorectal Cancer
3
An Oncodermatologist’s Perspective on Dermatological Toxicities in Breast Cancer
4
What Path to Approval Has Dasatinib Taken in CML/ALL?
5
